RANBAXY

Ranbaxy Laboratories Limited has informed the Exchange that the Trading window will remain closed from January 15, 2015 to January 29, 2015 (both days inclusive) in terms of the provisions of the Company's Code for Prevention for Insider Trading,

Ranbaxy Laboratories Limited has informed the Exchange that the Registered office of the Company will shift within the city of Mohali effective January 1, 2011. The new address of the Registered Office is as under : Ranbaxy Laboratories Limited, A-41, Industrial Area Phase VIII-A, Sahibzada Ajit Singh Nagar, Mohali - 160 071 (Punjab).

Icici Securities Limited has informed the Exchange regarding Open Offer by Daiichi Sankyo Company Limited for acquisition of up 20% of emerging voting capital of Ranbaxy Laboratories Limited ("Offer"). The details of the same are as follows: "As Manager to the Offer, pursuant to Regulation 18(1) of the Regulation , the draft Letter of Offer has been submitted to Securities and Exhange Board of India ("SEBI") on June 27, 2008 on which observations in terms of Regulation 18(2) of the Regulations are being awaited. In term of the subject PA the last date for dispatch of the Letter of Offer was J